Efficacy and Safety Study of Iloperidone Virus Risperidone to Treat Schizophrenia

A Randomized, Double-Blind, Active-Controlled, Multicenter Study to Evaluate Efficacy and Safety Study of Iloperidone Virus Risperidone to Treat Schizophrenia

The purpose of this study is to determine whether iloperidone is effective in the treatment of Schizophrenia.

Inclusion Criteria:

• Men or women ages 18-65 years old.
• DSM-IV diagnosis of schizophrenia.
• PANSS≥70.
• Of the 7 PANSS positive symptom subscale, at least two score ≥ 4 points.
• Written informed consent.

Exclusion Criteria:

• Pregnant or nursing (lactating) women, or women who plan on conceiving during the course of the study.
• Clinically significant disease of the heart,kidneys,liver,hematonosis or endocrine system.